A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia (Q28249342)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
scientific article

    Statements

    A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia (English)
    0 references
    0 references
    Elaine Willmore
    0 references
    Sarah de Caux
    0 references
    Nicola J Sunter
    0 references
    Michael J Tilby
    0 references
    Graham H Jackson
    0 references
    Barbara W Durkacz
    0 references
    15 June 2004
    0 references
    0 references
    103
    0 references
    12
    0 references
    4659-65
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit